Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

180.59B

Market cap180.59B

Price-Earnings ratio

11.71

Price-Earnings ratio11.71

Dividend yield

3.02%

Dividend yield3.02%

Average volume

15.27M

Average volume15.27M

High today

$41.41

High today$41.41

Low today

$40.24

Low today$40.24

Open price

$41.25

Open price$41.25

Volume

11.58M

Volume11.58M

52 Week high

$81.44

52 Week high$81.44

52 Week low

$35.12

52 Week low$35.12

NVO News

TipRanks 1h

Novo Nordisk Maps Heart Risk in New Diabetes Patients Across Southeast Asia

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decision...

The Motley Fool 10h

Prediction: This 1 Thing Could Cement Eli Lilly's Leadership in the Billion-Dollar Weight Loss Drug Market

Eli Lilly (LLY 1.89%) has accomplished something big over the past year. It's become the leading weight loss drug company in the U.S., holding 60% market share....

Nasdaq 1d

The $1 Trillion Race: Why Eli Lilly Is Leaving Novo Nordisk in the Dust

Key Points Eli Lilly has a stronger weight-loss portfolio than Novo Nordisk. Eli Lilly also has a deep pipeline beyond its core therapeutic area. Novo Nordis...

Analyst ratings

63%

of 35 ratings

Buy

31.4%

Hold

62.9%

Sell

5.7%

More NVO News

Simply Wall St 1d

Is Novo Nordisk Now An Opportunity After Recent Share Price Weakness?

If you are wondering whether Novo Nordisk's current share price still reflects its long term potential, the key question is how its fundamentals stack up agains...

Investor's Business Daily 2d

Big Pharma Deepens AI Ties. What It Means For Novo, Novartis.

Technology Big Pharma Deepens AI Ties. What It Means For Novo, Novartis. Licensing Novo Nordisk (NVO) and Novartis (NVS) have forged deeper ties to AI trailblaz...

TipRanks 2d

Novo Nordisk Stock Is Cheap and Offers a 5% Dividend Yield

The stock of European pharmaceutical giant Novo Nordisk (NVO) is cheap at current levels and offers shareholders a hefty dividend yield of nearly 5%. Claim 30%...

MarketWatch 2d

Novo Nordisk’s stock rallies after drugmaker reveals deal with OpenAI

Novo Nordisk is working with OpenAI on a broad deal that will use artificial intelligence to more quickly develop new medications as well as help train its work...

Benzinga 2d

Novo Nordisk Expands AI Push With ChatGPT Parent OpenAI

AI To Accelerate Drug Discovery The collaboration will leverage advanced AI tools to analyze complex datasets, identify promising drug candidates, and streamli...

Barron's 2d

Novo Nordisk Stock Rises. An OpenAI Partnership Can Help It Find the Next Ozempic.

Biotech and Pharma Novo Nordisk Stock Rises. An OpenAI Partnership Can Help It Find the Next Ozempic. In this article NVO SPX LLY Novo Nordisk will work with Op...

TipRanks 2d

Novo Nordisk partners with OpenAI to speed drug development

Novo Nordisk (NVO) announced a strategic partnership with OpenAI that it says will place Novo Nordisk at the forefront of AI transformation in healthcare and he...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.